Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Oct 13, 2022 9:45 AM - Oct 14, 2022 4:30 PM

(US Eastern Standard Time)

Digital Technology in Clinical Trials Conference

Digital Technology in Clinical Trials Conference is now fully virtual. Join us from the comfort of your own space!

Session 2: Lessons Learned and Best Practices for Decentralized Clinical Trials: Can We Plan and Execute More Patient-Friendly Clinical Trials?

Session Chair(s)

Megan  Doyle, JD, MPH

Megan Doyle, JD, MPH

Associate Vice President, Assistant General Counsel - Diagnostics

Eli Lilly & Company, United States

This session will focus on what we’ve learned thus far in trying to implement decentralized techniques in clinical trials. Specifically, speakers will share lessons learned and best practices observed to date. Additionally, based on these lessons learned, we will discuss remaining challenges and paths forward for addressing those challenges.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Articulate best practices in planning and executing decentralized trials
  • Understand some lessons learned related to using decentralized techniques in clinical trials to date
  • Assess the challenges that remain for broad scale decentralized trial adoption

Speaker(s)

Scott  Askin, MSc

Speakers

Scott Askin, MSc

Novartis Pharma AG, Switzerland

Global Program Regulatory Director

Abba Elizabeth  Theogaraj, PhD

Speaker

Abba Elizabeth Theogaraj, PhD

Roche, Switzerland

Regulatory Senior Group Director

Reem  Yunis, PhD

Speaker

Reem Yunis, PhD

Medable, United States

Vice President, Digital Transformation Strategy

Sarah  Krug, MS

Speaker

Sarah Krug, MS

CANCER101, United States

Executive Director

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.